Ionis Pharmaceuticals, Inc. (LON:0JDI)
London · Delayed Price · Currency is GBP · Price in USD 82.09
-1.18 (-1.41%)
Feb 12, 2026, 5:08 PM GMT
Ionis Pharmaceuticals Employees
Ionis Pharmaceuticals had 1,069 employees as of December 31, 2024. The number of employees increased by 142 or 15.32% compared to the previous year.
Employees
1,069
Change (1Y)
142
Growth (1Y)
15.32%
Revenue / Employee
672.93K GBP
Profits / Employee
-178.39K GBP
Market Cap
10.01B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 1,069 | 142 | 15.32% |
| Dec 31, 2023 | 927 | 131 | 16.46% |
| Dec 31, 2022 | 796 | 136 | 20.61% |
| Dec 31, 2021 | 660 | -97 | -12.81% |
| Dec 31, 2020 | 757 | -60 | -7.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Convatec Group | 10,000 |
| Hikma Pharmaceuticals | 9,500 |
| CVS Group | 8,850 |
| Genus | 3,190 |
Ionis Pharmaceuticals News
- 6 days ago - Ionis Pharmaceuticals (IONS) Sees Price Target Raised by Piper Sandler | IONS Stock News - GuruFocus
- 9 days ago - Insider Sell: Eugene Schneider Sells Shares of Ionis Pharmaceuticals Inc (IONS) - GuruFocus
- 19 days ago - Insider Sell Alert: Shannon Devers Sells Shares of Ionis Pharmaceuticals Inc (IONS) - GuruFocus
- 22 days ago - Ionis, Otsuka win EU nod for hereditary angioedema therapy - Seeking Alpha
- 22 days ago - EU Approves DAWNZERA For Hereditary Angioedema, Says Ionis And Otsuka - Nasdaq
- 22 days ago - Ionis Pharmaceuticals (IONS) Gains EU Approval for Dawnzera - GuruFocus
- 22 days ago - DAWNZERA™ (donidalorsen) approved in the European Union for hereditary angioedema (HAE) - Business Wire
- 23 days ago - Ionis: Expected 2026 Launch Of Olezarsen In SHTG To Spur Leap In Revenue Growth - Seeking Alpha